Medical Device Inc. (d/b/a Arterex) announced on June 19 that it acquired NextPhase Medical Devices LLC for an undisclosed price.
NextPhase is a class II and III medical device contract manufacturer of electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory and supply chain and logistics management services, enabling its customers to bring low-to-medium volume complex medical devices to market.
Arterex is a leading medical device contract manufacturer and leader in new product development and medical education in orthopedics. The company has pioneered the field of arthroscopy and developed more than 1,000 innovative products and surgical procedures each year to advance minimally invasive orthopedics. It is based in Naples, Florida and has offices in Munich, Mexico City and Singapore. Investindustrial invested in the company in October 2022, from Investindustrial Growth III fund. The fund closed in May 2023 at more than $1.2 billion.
This acquisition doubles the size of Arterex’s group and creates a top-tier global medical device contract manufacturer with 70% of its revenues generated in the United States. This is the first acquisition since Arterex was bought by Investindustrial. Terms were not disclosed.
According to data captured in the LevinPro HC database, this transaction marks the 56th Medical Devices acquisition of 2023. Private Equity buyers represent 34% of Medical Devices buyers since the start of the year.
